These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6271620)
1. Effects of a converting enzyme inhibitor and angiotensin antagonists on the rat pressor effect of angiotensin-like substance formed by goosefish Stannius corpuscles and homologous plasma. Pang PK; Yang MC Gen Comp Endocrinol; 1981 Nov; 45(3):402-5. PubMed ID: 6271620 [No Abstract] [Full Text] [Related]
2. Blockade of angiotensin pressor activity in the freshwater turtle. Stephens GA Gen Comp Endocrinol; 1981 Nov; 45(3):364-71. PubMed ID: 6117503 [No Abstract] [Full Text] [Related]
3. Angiotensin peptides stimulate phosphoinositide breakdown and prolactin release in anterior pituitary cells in culture. Canonico PL; MacLeod RM Endocrinology; 1986 Jan; 118(1):233-8. PubMed ID: 3000736 [TBL] [Abstract][Full Text] [Related]
4. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients. Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501 [No Abstract] [Full Text] [Related]
5. Synthesis of nonmammalian angiotensins and their comparative pressor properties in dogfish shark, domestic chicken, and rat. Khosla MC; Bumpus FM; Nishimura H; Opdyke DF; Coviello A Hypertension; 1983; 5(6 Pt 3):V22-8. PubMed ID: 6654463 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients]. Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833 [No Abstract] [Full Text] [Related]
7. Converting-enzyme inhibition and 1-sarcosine-8-isoleucine-angiotensin II: effects on renal function in the dehydrated sheep. Yesberg NE; Henderson M; Dallemagne C; Law S; Hamilton D; Cross RB Q J Exp Physiol; 1984 Jan; 69(1):133-43. PubMed ID: 6371881 [TBL] [Abstract][Full Text] [Related]
8. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril. Zawada ET; Stinson J; Ramirez G Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479 [TBL] [Abstract][Full Text] [Related]
9. Hypotensive response to angiotensin II analogue and angiotensin I converting enzyme inhibitor in pseudo-Bartter's syndrome. Sasaki H; Kawasaki T; Fujisawa M; Motooka Y; Asano T; Okumura M Jpn Heart J; 1981 Jul; 22(4):689-93. PubMed ID: 6272003 [TBL] [Abstract][Full Text] [Related]
10. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
11. Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats. Tomlinson KC; Gardiner SM; Bennett T J Cardiovasc Pharmacol; 1990 Apr; 15(4):562-8. PubMed ID: 1691384 [TBL] [Abstract][Full Text] [Related]
12. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system. McCaa RE Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367 [TBL] [Abstract][Full Text] [Related]
13. Responsiveness to pressor agents in experimental renovascular and steroid hypertension. Effects of converting enzyme inhibitor and nephrectomy. Marks ES; Bing RF; Thurston H; Russell GI; Swales JD Hypertension; 1982; 4(2):238-44. PubMed ID: 6279494 [No Abstract] [Full Text] [Related]
14. The role of brain angiotensin II in the mechanism of the pressor responses to intracisternal injection of hypertonic NaCl in urethane anesthetized rats. Takeda K; Takahashi H; Ashizawa H; Inoue A; Shikuma R; Takashina R; Yoshimura M; Nakagawa M; Ijichi H Jpn Circ J; 1982 May; 46(5):534-9. PubMed ID: 7043019 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II facilitation of pressor responses to adrenal field stimulation in pithed rats. Vollmer RR; Corey SP; Fluharty SJ Am J Physiol; 1988 Jan; 254(1 Pt 2):R95-101. PubMed ID: 2892427 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin. Ohara N; Ono H; Hashimoto K Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844 [TBL] [Abstract][Full Text] [Related]
17. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903 [TBL] [Abstract][Full Text] [Related]
18. Hypotensive action of captopril and saralasin in intact and anephric spontaneously hypertensive rats. Hutchinson JS; Mendelsohn FA; Doyle AE Hypertension; 1980; 2(2):119-24. PubMed ID: 6991407 [TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of captopril induced hypotension in rats. Clarke DE; Wagner LB; Wagner LA Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats. Baum T; Becker FT; Sybertz EJ Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]